Filtros : "Indexado no Medline" "Indexado no Pub Med" "Cancer Immunology Immunotherapy" Removido: "HU" Limpar

Filtros



Refine with date range


  • Source: Cancer Immunology Immunotherapy. Unidade: ICB

    Assunto: IMUNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NEVES, Andreia R. et al. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunology Immunotherapy, v. 54, p. 61-66, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00262-004-0550-8. Acesso em: 28 out. 2024.
    • APA

      Neves, A. R., Ensina, L. F. C., Anselmo, L. B., Leite, K. R. M., Buzaid, A. C., Câmara-Lopes, L. H., & Barbuto, J. A. M. (2005). Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunology Immunotherapy, 54, 61-66. doi:10.1007/s00262-004-0550-8
    • NLM

      Neves AR, Ensina LFC, Anselmo LB, Leite KRM, Buzaid AC, Câmara-Lopes LH, Barbuto JAM. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 61-66.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s00262-004-0550-8
    • Vancouver

      Neves AR, Ensina LFC, Anselmo LB, Leite KRM, Buzaid AC, Câmara-Lopes LH, Barbuto JAM. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 61-66.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s00262-004-0550-8
  • Source: Cancer Immunology Immunotherapy. Unidade: ICB

    Assunto: FISIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Thais Martins et al. Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death. Cancer Immunology Immunotherapy, v. 54, p. 179-186, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00262-004-0570-4. Acesso em: 28 out. 2024.
    • APA

      Lima, T. M., Lima, M. M. R., Almeida, D. C. G., Mendonça, J. R., & Curi, R. (2005). Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death. Cancer Immunology Immunotherapy, 54, 179-186. doi:10.1007/s00262-004-0570-4
    • NLM

      Lima TM, Lima MMR, Almeida DCG, Mendonça JR, Curi R. Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 179-186.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s00262-004-0570-4
    • Vancouver

      Lima TM, Lima MMR, Almeida DCG, Mendonça JR, Curi R. Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 179-186.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s00262-004-0570-4

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024